Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
47.85
-2.50 (-4.97%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Thera
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Why Is Viking Therapeutics (VKTX) Stock Up 38% Today?
March 28, 2023
Viking Therapeutics (VKTX) stock is climbing higher on Tuesday after initiating a Phase 1 clinical trial of weight loss drug VK2735.
Via
InvestorPlace
Why Viking Therapeutics Stock Is Soaring Tuesday
March 28, 2023
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 28, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!
Via
InvestorPlace
Is Viking Therapeutics a Smart Buy on the Dip?
March 27, 2023
The stock recently fell around 25% for reasons that had nothing to do with its lead program.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 21, 2023
Via
Benzinga
4 Analysts Have This to Say About Viking Therapeutics
March 17, 2023
Via
Benzinga
2 Surging Healthcare Stocks That Are Still Worth Buying
February 23, 2023
These two NASH drugmakers have a lot of room to run.
Via
The Motley Fool
Viking Therapeutics's Earnings: A Preview
February 07, 2023
Via
Benzinga
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 21, 2023
Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.
Via
Benzinga
Analyzing Viking Therapeutics's Short Interest
January 03, 2023
Viking Therapeutics's (NASDAQ:VKTX) short percent of float has risen 7.17% since its last report. The company recently reported that it has 1.89 million shares sold short, which is 2.54% of all regular...
Via
Benzinga
5 Most Expensive Health Care Stocks You Should Worry About
January 03, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
December 23, 2022
Via
Benzinga
Recap: Viking Therapeutics Q3 Earnings
October 26, 2022
Viking Therapeutics (NASDAQ:VKTX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
This Stock That Tripled in 2022 Could Rocket Even Higher in 2023
December 26, 2022
Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results.
Via
The Motley Fool
Why Did Viking Therapeutics Stock Skyrocket
December 21, 2022
VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial.
Via
MarketBeat
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 19, 2022
Via
Benzinga
Is Elon Musk Stepping Down as Head of Twitter?
December 19, 2022
Elon Musk is in the news Monday after the billionaire held a poll asking if he should step down as head of social media company Twitter.
Via
InvestorPlace
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
December 19, 2022
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Is Cosmos Health (COSM) Stock Down 58% Today?
December 19, 2022
Cosmos Health (COSM) stock is falling hard on Monday after the healthcare company's shares underwent a major rally on Friday!
Via
InvestorPlace
Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning
December 19, 2022
Good news can come in different forms.
Via
The Motley Fool
Why Is Viking Therapeutics (VKTX) Stock Up 67% Today?
December 19, 2022
Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company.
Via
InvestorPlace
US Stocks Slightly Lower; Nasdaq Down 100 Points
December 19, 2022
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 100 points on Monday.
Via
Benzinga
Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today
December 19, 2022
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 19, 2022
Via
Benzinga
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
Biotech stocks are set to shine in 2023.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 16, 2022
Via
Benzinga
Earnings Outlook For Viking Therapeutics
October 25, 2022
Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Viking...
Via
Benzinga
Earnings Scheduled For October 26, 2022
October 26, 2022
Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion.
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.